These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 8531377)

  • 1. [Lymphoproliferative disorders in patients with Sjögren's syndrome--Vg gene rearrangement and expression of bcl-2 protein].
    Sugai S; Takeshita S; Ogawa Y; Masaki Y; Doumiki T; Takeuchi Y
    Nihon Rinsho; 1995 Oct; 53(10):2580-6. PubMed ID: 8531377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rearrangement of the rheumatoid factor-related germline gene Vg and bcl-2 expression in lymphoproliferative disorders in patients with Sjögren's syndrome.
    Sugai S; Saito I; Masaki Y; Takeshita S; Shimizu S; Tachibana J; Miyasaka N
    Clin Immunol Immunopathol; 1994 Aug; 72(2):181-6. PubMed ID: 8050191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Sjögren's syndrome as a lymphoaggressive disorder; bcl-2 expression in lymphocytes infiltrated in salivary glands].
    Takeshita S; Sugai S
    Nihon Rinsho; 1995 Oct; 53(10):2440-5. PubMed ID: 8531352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphoproliferative disorders in Japanese patients with Sjögren's syndrome.
    Sugai S; Shimizu S; Konda S
    Scand J Rheumatol Suppl; 1986; 61():118-22. PubMed ID: 3473620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphoproliferative disorders in Sjögren's syndrome.
    Masaki Y; Sugai S
    Autoimmun Rev; 2004 Mar; 3(3):175-82. PubMed ID: 15110228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of CD40/CD40 ligand and Bcl-2 family proteins in labial salivary glands of patients with Sjögren's syndrome.
    Nakamura H; Kawakami A; Tominaga M; Migita K; Kawabe Y; Nakamura T; Eguchi K
    Lab Invest; 1999 Mar; 79(3):261-9. PubMed ID: 10092062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T cell receptor repertoire in B cell lymphoproliferative lesions in primary Sjögren's syndrome.
    Pivetta B; De Vita S; Ferraccioli G; De Re V; Gloghini A; Marzotto A; Caruso G; Dolcetti R; Bartoli E; Carbone A; Boiocchi M
    J Rheumatol; 1999 May; 26(5):1101-9. PubMed ID: 10332975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Sjögren's syndrome associated with non-Hodgkin's lymphoma].
    Nagai K
    Nihon Rinsho; 1995 Oct; 53(10):2574-9. PubMed ID: 8531376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sjögren's syndrome.
    Ioannidis JP; Vassiliou VA; Moutsopoulos HM
    Arthritis Rheum; 2002 Mar; 46(3):741-7. PubMed ID: 11920410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preliminary classification of nonmalignant B cell proliferation in Sjögren's syndrome: perspectives on pathobiology and treatment based on an integrated clinico-pathologic and molecular study approach.
    De Vita S; De Marchi G; Sacco S; Gremese E; Fabris M; Ferraccioli G
    Blood Cells Mol Dis; 2001; 27(4):757-66. PubMed ID: 11778660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salivary gland B cell lymphoproliferative disorders in Sjögren's syndrome present a restricted use of antigen receptor gene segments similar to those used by hepatitis C virus-associated non-Hodgkins's lymphomas.
    De Re V; De Vita S; Gasparotto D; Marzotto A; Carbone A; Ferraccioli G; Boiocchi M
    Eur J Immunol; 2002 Mar; 32(3):903-10. PubMed ID: 11870635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Malignancy in autoimmune diseases].
    Sugai S
    Nihon Rinsho Meneki Gakkai Kaishi; 1996 Feb; 19(1):1-14. PubMed ID: 8681020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salivary gland lymphomas in patients with Sjögren's syndrome may frequently develop from rheumatoid factor B cells.
    Martin T; Weber JC; Levallois H; Labouret N; Soley A; Koenig S; Korganow AS; Pasquali JL
    Arthritis Rheum; 2000 Apr; 43(4):908-16. PubMed ID: 10765938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Sjogren's syndrome and lymphoproliferative lesions].
    Sugai S
    Nihon Naika Gakkai Zasshi; 2000 Sep; 89(9):1948-56. PubMed ID: 11051677
    [No Abstract]   [Full Text] [Related]  

  • 15. [Prognostic implications of mixed monoclonal cryoglobulinemia in Sjogren's disease].
    Vasil'ev VI; Probatova NA; Varlamova EIu; Tupitsin NN; Simonova MV; Safonova TN; Bozh'eva LA; Shornikova NS; Logvinenko OA; Belenin GIu
    Ter Arkh; 2004; 76(8):61-8. PubMed ID: 15471400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical aspects and types of Sjögren's syndrome].
    Sugai S; Takeshita S; Ogawa Y; Fukutoku M; Masaki Y
    Nihon Rinsho; 1995 Oct; 53(10):2376-82. PubMed ID: 8531341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secondary tumours in Sjögren's syndrome.
    Kovács L; Szodoray P; Kiss E
    Autoimmun Rev; 2010 Feb; 9(4):203-6. PubMed ID: 19602455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of a cross-reactive idiotype on rheumatoid factor in patients with Sjogren's syndrome.
    Fox RI; Chen P; Carson DA; Fong S
    J Immunol; 1986 Jan; 136(2):477-83. PubMed ID: 3079786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphoma development in Sjögren's syndrome: novel p53 mutations.
    Tapinos NI; Polihronis M; Moutsopoulos HM
    Arthritis Rheum; 1999 Jul; 42(7):1466-72. PubMed ID: 10403275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of B cell lymphoma in patients with Sjögren's syndrome and hepatitis C virus infection.
    Ramos-Casals M; la Civita L; de Vita S; Solans R; Luppi M; Medina F; Caramaschi P; Fadda P; de Marchi G; Lopez-Guillermo A; Font J;
    Arthritis Rheum; 2007 Feb; 57(1):161-70. PubMed ID: 17266090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.